Ayala Pharmaceuticals, Inc. (ADXS) Financials
Stock symbol ADXS is outdated, potentially delisted? Maybe it is available on other exchange?
ADXS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Oct. 31, 2023 | 7.0 million | 13.2 million |
| July 31, 2023 | 12.2 million | 11.1 million |
| April 30, 2023 | 21.0 million | 11.3 million |
| Jan. 31, 2023 | 25.9 million | 2.3 million |
ADXS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Oct. 31, 2023 | -7.0 million | 89000 |
| July 31, 2023 | -7.0 million | 89000 |
| April 30, 2023 | -6.7 million | 1.2 million |
| Jan. 31, 2023 | -2.8 million | 23000 |
ADXS Net Income
No data available :(
ADXS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Oct. 31, 2023 | 2.1 million | - | - |
| July 31, 2023 | 7.1 million | - | 1.4 million |
| April 30, 2023 | 16.8 million | - | 1.5 million |
| Jan. 31, 2023 | 25.2 million | - | 1.7 million |
ADXS Shares Outstanding
ADXS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Oct. 31, 2023 | - | 5.7 million | 1.4 million | - |
| July 31, 2023 | - | 5.7 million | 2.8 million | - |
| April 30, 2023 | - | 7.3 million | 4.6 million | - |
| Jan. 31, 2023 | 201000 | 2.2 million | 2.6 million | - |
ADXS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Oct. 31, 2023 | - | 7.1 million |
| July 31, 2023 | 9000 | 9000 |
| April 30, 2023 | 4000 | 4000 |
| Jan. 31, 2023 | 250000 | 91000 |
ADXS
Price: $0.60
52 week price:
Earnings Per Share: -7.99 USD
P/E Ratio: -0.08
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 5364
Ebitda: -27.5 millionMarket Capitalization: 25.7 million